News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
How Cancers Evolve Drug Resistance
Anna Azvolinsky | Apr 1, 2017
Researchers unravel the sophisticated ways cancers evade treatments, including immunotherapies, designed to destroy them.
Infographic: Targeting Cancer Antigens
Stephen P. Schoenberger and Ezra Cohen | Mar 31, 2017
Neoantigens may serve as valuable targets for new immunotherapies.
Infographic: Mechanisms of Resistance
Anna Azvolinsky | Mar 31, 2017
Cancers appear to be able to evolve resistance to many of the therapies doctors have tried.
Newly Found White Blood Cell Withstands Chemotherapy
Ben Andrew Henry | Jan 1, 2017
Vaccine-induced macrophages open a new realm of study into remodeling the immune system to reduce the risk of infections during cancer treatment.
Opinion: Balancing Risks and Rewards of CAR T-Cell Therapy
David Harris | Dec 15, 2016
New approaches to treating cancer have shown great promise, but they also come with serious risks that give us cause for concern.
Pfizer to Buy Medivation for $14 Billion
Bob Grant | Aug 22, 2016
The pharma giant is purchasing the San Francisco–based cancer drugmaker to boost its oncology portfolio.
Renowned Cancer Theorist Dies
Alison F. Takemura | Jul 12, 2016
Alfred Knudson, who formulated the “two-hit” theory on the origins of cancer, has passed away at age 93.
New FDA Center Aims to Expedite Cancer Treatment Reviews
Alison F. Takemura | Jun 30, 2016
The Oncology Center of Excellence, a product of the White House’s Cancer Moonshot initiative, will bring together oncologists across the US Food and Drug Administration.
Thirumala-Devi Kanneganti: Immersed in Immunology
Karen Zusi | Jun 1, 2016
Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43
AACR Q&A: Angelika Amon
Staff | Apr 19, 2016
The aneuploidy expert shares what she has learned at the American Association for Cancer Research annual meeting.